PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure
NCT ID: NCT00279955
Last Updated: 2012-06-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1024 participants
OBSERVATIONAL
2004-06-30
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PROSPECT: Predictors of Response to Cardiac Re-Synchronization Therapy
NCT00253357
TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients
NCT00345592
Ensure Cardiac Resynchronization Therapy Study
NCT00291564
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial
NCT00251251
INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients With Remotely Monitored Implanted Cardioverter Defibrillators (ICD) SysTems
NCT01200381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac Resynchronization Therapy Device
Patients with an ICD indication, a CRT indication and symptomatic heart failure who are implanted with a Cardiac Resynchronization Therapy Device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with Class III or IV heart failure.
* Patients receiving or who received a Medtronic CRT ICD within the previous 3 months.
* Patient must sign and date informed consent, and be 18 years of age or greater.
* Patient must be available for follow up visits, and be willing and able to comply with study protocol.
Exclusion Criteria
* Patient with a mechanical right heart valve.
* Patient with chronic (permanent) atrial arrhythmias.
* Patient with life expectancy of less than 12 months.
* Patient with status post heart transplant
* Patient undergoing kidney dialysis
* Patients enrolled in a concurrent study that may confound the results of the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Whellan, MD
Role: PRINCIPAL_INVESTIGATOR
Jefferson Heart Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Huntsville, Alabama, United States
Phoenix, Arizona, United States
Scottsdale, Arizona, United States
Little Rock, Arkansas, United States
Loma Linda, California, United States
San Diego, California, United States
Denver, Colorado, United States
Guilford, Connecticut, United States
Bradenton, Florida, United States
Fort Lauderdale, Florida, United States
Key Largo, Florida, United States
Melbourne, Florida, United States
Miami, Florida, United States
Orlando, Florida, United States
Palm Beach Gardens, Florida, United States
Pensacola, Florida, United States
Safety Harbor, Florida, United States
Tallahassee, Florida, United States
Tampa, Florida, United States
Winter Park, Florida, United States
Atlanta, Georgia, United States
Augusta, Georgia, United States
Honolulu, Hawaii, United States
Evanston, Illinois, United States
Maywood, Illinois, United States
Merrionette Park, Illinois, United States
Rockford, Illinois, United States
Springfield, Illinois, United States
Winfield, Illinois, United States
Topeka, Kansas, United States
Wichita, Kansas, United States
Edgewood, Kentucky, United States
Florence, Kentucky, United States
Louisville, Kentucky, United States
Covington, Louisiana, United States
Monroe, Louisiana, United States
Portland, Maine, United States
Salisbury, Maryland, United States
Takoma Park, Maryland, United States
Grand Rapids, Michigan, United States
Marquette, Michigan, United States
Petoskey, Michigan, United States
Traverse City, Michigan, United States
Minneapolis, Minnesota, United States
Saint Cloud, Minnesota, United States
St Louis, Missouri, United States
Missoula, Montana, United States
Las Vegas, Nevada, United States
Manchester, New Hampshire, United States
Cherryhill, New Jersey, United States
Ridgewood, New Jersey, United States
Sewell, New Jersey, United States
New York, New York, United States
The Bronx, New York, United States
West Islip, New York, United States
Williamsville, New York, United States
Charlotte, North Carolina, United States
Durham, North Carolina, United States
Greensboro, North Carolina, United States
Raleigh, North Carolina, United States
Bismarck, North Dakota, United States
Fargo, North Dakota, United States
Cincinnati, Ohio, United States
Columbus, Ohio, United States
Dayton, Ohio, United States
Elyria, Ohio, United States
Lakewood, Ohio, United States
Mayfield Heights, Ohio, United States
Westlake, Ohio, United States
Medford, Oregon, United States
Camp Hill, Pennsylvania, United States
Erie, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Wormleysburg, Pennsylvania, United States
York, Pennsylvania, United States
Pawtucket, Rhode Island, United States
Providence, Rhode Island, United States
Columbia, South Carolina, United States
Spartanburg, South Carolina, United States
Sioux Falls, South Dakota, United States
Knoxville, Tennessee, United States
Nashville, Tennessee, United States
Fairfax, Texas, United States
Fort Worth, Texas, United States
Lubbock, Texas, United States
Burlington, Vermont, United States
Lynchburg, Virginia, United States
Norfolk, Virginia, United States
Richmond, Virginia, United States
Kirkland, Washington, United States
Green Bay, Wisconsin, United States
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, O'Connor CM; PARTNERS Study Investigators. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol. 2010 Apr 27;55(17):1803-10. doi: 10.1016/j.jacc.2009.11.089.
Whellan DJ, O'Connor CM, Ousdigian KT, Lung TH; PARTNERS HF Study Investigators. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF). Am Heart J. 2008 Nov;156(5):833-9, 839.e2. doi: 10.1016/j.ahj.2008.06.036. Epub 2008 Sep 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
235
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.